Context Therapeutics Inc (CNTX): ugh hope the breakfast was really good...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	4050
Posts	152184
Boards Moderated	3
Alias Born	08/05/2009

TheFinalCD

Re: reena969 post# 53

Tuesday, 01/31/2023 9:12:52 AM

Tuesday, January 31, 2023 9:12:52 AM

ugh hope the breakfast was really good

but how much did it cost ya frown

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions~!

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CNTX News

Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:33:19 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:22:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 11:34:25 AM
Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors • GlobeNewswire Inc. • 09/04/2024 11:30:47 AM
Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 08:17:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:07:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:18:30 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:15:17 PM
Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/24/2024 09:07:18 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/24/2024 08:55:48 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/12/2024 08:04:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:33:59 AM
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95 • GlobeNewswire Inc. • 07/10/2024 11:30:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 11:50:14 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:34:52 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/03/2024 04:15:21 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/31/2024 08:06:51 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/24/2024 08:15:19 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/24/2024 11:31:07 AM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/10/2024 08:00:06 PM
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 05/08/2024 08:06:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:03:39 PM

More CNTX News

InvestorsHub NewsWire

North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover